SciELO - Scientific Electronic Library Online

 
vol.57 issue4High prevalence and poor control of hypertension in five venezuelan populations: the VEMSOLS studyPAGOD syndrome and vascular anomalies: is a defect embryonic angiogenesis? A case report and review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Investigación Clínica

Print version ISSN 0535-5133

Abstract

LOPEZ-VASQUEZ, Lucía; ALBANEZ, Silvia; PESTANA, Carolina  and  PORCO, Antonietta. Detection of F8 mutations in carriers and patients with severe hemophilia A: Identification of a novel mutation. Invest. clín [online]. 2016, vol.57, n.4, pp.377-387. ISSN 0535-5133.

The molecular diagnosis of haemophilia A (HA) patients has many benefits including diagnosis confirmation and inhibitor risk development prediction. In female carries of a mutation, the molecular diagnosis allows for genetic counseling and prenatal diagnosis, which have become part of the comprehensive care for HA in many countries. Therefore, the aim of this study was to determine the F8 mutations in severe HA (sHA) patients and female carriers. In 12 patients with sHA, the presence of the intron 22 and intron 1 inversions was investigated using an inverse and a conventional PCR method, respectively. In patients negative for the inversions, the F8 gene was screened through conformation sensitive gel electrophoresis (CSGE) and further sequencing. The causative mutation was successfully identified in 6/12 patients, including the novel mutation p.G190C. The mothers of these six patients and those of seven other sHA patients molecularly diagnosed in a previous work were investigated for the presence of the genetic alterations found in their sons. All mothers were found to be carriers. This is the first study conducted in Venezuela which directly analyzes the F8 gene in potential carrier mothers to specifically identify the presence of the mutation that was detected in their sons, and complements a previous study on sHA patients. Our findings will facilitate the implementation of regular screening of HA carriers in our country and will allow a better care of bleeding symptoms and genetic counseling.

Keywords : carrier; factor VIII; molecular diagnosis; mutation; hemophilia A; Venezuela.

        · abstract in Spanish     · text in English     · English ( pdf )